Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Assets Average (2019 - 2025)

Historic Assets Average for TransMedics (TMDX) over the last 7 years, with Q3 2025 value amounting to $918.3 million.

  • TransMedics' Assets Average rose 1893.64% to $918.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $918.3 million, marking a year-over-year increase of 1893.64%. This contributed to the annual value of $755.1 million for FY2024, which is 5359.36% up from last year.
  • Per TransMedics' latest filing, its Assets Average stood at $918.3 million for Q3 2025, which was up 1893.64% from $864.0 million recorded in Q2 2025.
  • TransMedics' Assets Average's 5-year high stood at $918.3 million during Q3 2025, with a 5-year trough of $120.6 million in Q2 2022.
  • Over the past 5 years, TransMedics' median Assets Average value was $488.7 million (recorded in 2023), while the average stood at $477.2 million.
  • In the last 5 years, TransMedics' Assets Average crashed by 1575.43% in 2021 and then skyrocketed by 30508.68% in 2023.
  • TransMedics' Assets Average (Quarter) stood at $133.0 million in 2021, then soared by 107.5% to $276.0 million in 2022, then surged by 152.76% to $697.6 million in 2023, then grew by 13.93% to $794.8 million in 2024, then grew by 15.53% to $918.3 million in 2025.
  • Its Assets Average stands at $918.3 million for Q3 2025, versus $864.0 million for Q2 2025 and $820.8 million for Q1 2025.